Korea approves Ono Pharma's Qinlock for advanced GIST (Korea Biomedical Review) - Oct 19, 2026 - "The MFDS previously designated Qinlock as the 55th product under its Global Innovative Products on Fast Track (GIFT) program and conducted an expedited review."
Korea approval • Gastrointestinal Stromal Tumor
|